Sialyltransferase Activity and Atherosclerosis
Overview
Authors
Affiliations
Sialic acid in the regulation of blood cell production, differentiation and turnover.
Irons E, Gc S, Lau J Immunology. 2024; 172(4):517-532.
PMID: 38503445 PMC: 11223974. DOI: 10.1111/imm.13780.
Lipoprotein sialylation in atherosclerosis: Lessons from mice.
Yu L, Peng J, Mineo C Front Endocrinol (Lausanne). 2022; 13:953165.
PMID: 36157440 PMC: 9498574. DOI: 10.3389/fendo.2022.953165.
Sialic acid metabolism as a potential therapeutic target of atherosclerosis.
Zhang C, Chen J, Liu Y, Xu D Lipids Health Dis. 2019; 18(1):173.
PMID: 31521172 PMC: 6745061. DOI: 10.1186/s12944-019-1113-5.
Recombinant Sialyltransferase Infusion Mitigates Infection-Driven Acute Lung Inflammation.
Nasirikenari M, Lugade A, Neelamegham S, Gao Z, Moremen K, Bogner P Front Immunol. 2019; 10:48.
PMID: 30778346 PMC: 6369197. DOI: 10.3389/fimmu.2019.00048.
The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis.
Dougher C, Buffone Jr A, Nemeth M, Nasirikenari M, Irons E, Bogner P J Leukoc Biol. 2017; 102(2):507-516.
PMID: 28550122 PMC: 5505748. DOI: 10.1189/jlb.3A1216-538RR.